世界の特殊ジェネリック医薬品市場予測2022年-2027年

【英語タイトル】Specialty Generics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

IMARCが出版した調査資料(IMARC22JN916)・商品コード:IMARC22JN916
・発行会社(調査会社):IMARC
・発行日:2022年3月
・ページ数:140
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD2,499 ⇒換算¥332,367見積依頼/購入/質問フォーム
Five UserUSD3,499 ⇒換算¥465,367見積依頼/購入/質問フォーム
EnterprisewideUSD4,499 ⇒換算¥598,367見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
IMARCでは、世界の特殊ジェネリック医薬品市場規模が2021年608億ドルから2027年1151億ドルに達し、2022年から2027年まで年平均11.11%成長すると予測しています。本調査レポートでは、特殊ジェネリック医薬品の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、収益となる理由、投与経路別(注射剤、経口剤、その他)分析、疾患別(がん、自己免疫疾患、感染症、その他)分析、流通チャネル別(小売薬局、専門薬局、病院薬局)分析、地域別分析、競争状況などの項目を掲載しています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・収益となる理由
・世界の特殊ジェネリック医薬品市場規模:投与経路別(注射剤、経口剤、その他)
・世界の特殊ジェネリック医薬品市場規模:疾患別(がん、自己免疫疾患、感染症、その他)
・世界の特殊ジェネリック医薬品市場規模:流通チャネル別(小売薬局、専門薬局、病院薬局)
・世界の特殊ジェネリック医薬品市場規模:地域別
・競争状況
❖ レポートの概要 ❖

The global specialty generics market reached a value of US$ 60.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 115.1 Billion by 2027, exhibiting at a CAGR of 11.11% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Specialty generics are generic versions of specialty drugs, once they get off-patent. These drugs are used to treat chronic or complex health conditions including cancer, autoimmune diseases, epilepsy, HIV, Hepatitis, multiple sclerosis, rheumatoid arthritis, etc. Speciality generics are cost-effective as compared to their branded versions as they don’t require costly development and marketing costs.

Compared to traditional generics, the speciality generics market is more concentrated with fewer players due to their complex manufacturing requirements, higher capital costs and relatively lower volumes as a result of smaller patient population. This results in lower price reduction compared to the branded drug and consequently higher margins compared to traditional generics. Speciality generics require special handling, administration, monitoring and generally need prior authorization to order them. The global speciality generics market is currently being driven by several factors such as rising ageing population, patent expiration of a number of branded specialty drugs, increasing prevalence of various life-threatening diseases such as cancer, multiple sclerosis, HIV, etc., cost containment measures from healthcare providers, growth from emerging markets, etc.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global specialty generics market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on route of administration, indication and distribution channel.

Breakup by Region:
North America
United States
Canada
Europe
Italy
Germany
Spain
United Kingdom
France
Asia-Pacific
China
India
Japan
South Korea
Latin America
Brazil
Mexico
Middle East and Africa

Breakup by Route of Administration:
Injectables
Oral
Others

Breakup by Indication:
Oncology
Autoimmune Diseases
Infectious Diseases
Others

Breakup by Distribution channel:
Retail Pharmacies
Specialty Pharmacies
Hospital Pharmacies

Competitive Landscape:
The global specialty generics market consists of numerous manufacturers. Some of the leading players operating in the market are Teva Pharmaceuticals Industries, Akorn, Inc., Mylan N.V., Mallinckrodt, Sandoz International GmbH, Pfizer, Inc., Sun Pharmaceutical Industries Ltd., Valeant Pharmaceuticals, Apotex Corp., Endo International plc.

IMARC Group’s latest report provides a deep insight into the global specialty generics market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the specialty generics market in any manner.

Key Questions Answered in This Report
1. What is the size of the global specialty generics market?
2. What are the key factors driving the global specialty generics market?
3. What has been the impact of COVID-19 on the global specialty generics market?
4. What is the breakup of the global specialty generics market based on the route of administration?
5. What is the breakup of the global specialty generics market based on the indication?
6. What is the breakup of the global specialty generics market based on the distribution channel?
7. What are the key regions in the global specialty generics market?
8. Who are the key players/companies in the global specialty generics market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Specialty Generics Market: Introduction
5 Why are Specialty Generics So Lucrative?
6 Global Specialty Generics Market
6.1 Market Overview
6.2 Market Performance
6.3 Impact of COVID-19
6.4 Market Breakup by Route of Administration
6.5 Market Breakup by Indication
6.6 Market Breakup by Distribution Channel
6.7 Market Breakup by Region
6.8 Market Forecast
6.9 SWOT Analysis
6.9.1 Overview
6.9.2 Strengths
6.9.3 Weaknesses
6.9.4 Opportunities
6.9.5 Threats
6.10 Value Chain Analysis
6.11 Porters Five Forces Analysis
6.11.1 Overview
6.11.2 Bargaining Power of Buyers
6.11.3 Bargaining Power of Suppliers
6.11.4 Degree of Competition
6.11.5 Threat of New Entrants
6.11.6 Threat of Substitutes
6.12 Key Market Drivers and Success Factors
7 Market Breakup by Route of Administration
7.1 Injectable
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Oral
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Indication
8.1 Oncology
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Autoimmune Diseases
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Infectious Diseases
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Specialty Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Hospital Pharmacies
9.3.1 Market Trends
9.3.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 Market Overview
10.1.2 Market Performance
10.1.3 Market Breakup by Country
10.1.3.1 United States
10.1.3.1.1 Market Trends
10.1.3.1.2 Market Forecast
10.1.3.2 Canada
10.1.3.2.1 Market Trends
10.1.3.2.2 Market Forecast
10.1.4 Market Forecast
10.2 Europe
10.2.1 Market Overview
10.2.2 Market Performance
10.2.3 Market Breakup by Country
10.2.3.1 Italy
10.2.3.1.1 Market Trends
10.2.3.1.2 Market Forecast
10.2.3.2 Germany
10.2.3.2.1 Market Trends
10.2.3.2.2 Market Forecast
10.2.3.3 France
10.2.3.3.1 Market Trends
10.2.3.3.2 Market Forecast
10.2.3.4 United Kingdom
10.2.3.4.1 Market Trends
10.2.3.4.2 Market Forecast
10.2.3.5 Spain
10.2.3.5.1 Market Trends
10.2.3.5.2 Market Forecast
10.2.4 Market Forecast
10.3 Asia Pacific
10.3.1 Market Overview
10.3.2 Market Performance
10.3.3 Market Breakup by Country
10.3.3.1 Japan
10.3.3.1.1 Market Trends
10.3.3.1.2 Market Forecast
10.3.3.2 China
10.3.3.2.1 Market Trends
10.3.3.2.2 Market Forecast
10.3.3.3 India
10.3.3.3.1 Market Trends
10.3.3.3.2 Market Forecast
10.3.3.4 South Korea
10.3.3.4.1 Market Trends
10.3.3.4.2 Market Forecast
10.3.4 Market Forecast
10.4 Latin America
10.4.1 Market Overview
10.4.2 Market Performance
10.4.3 Market Breakup by Country
10.4.3.1 Brazil
10.4.3.1.1 Market Trends
10.4.3.1.2 Market Forecast
10.4.3.2 Mexico
10.4.3.2.1 Market Trends
10.4.3.2.2 Market Forecast
10.4.4 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Overview
10.5.2 Market Performance
10.5.3 Market Forecast
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 Teva Pharmaceuticals Industries
11.3.2 Akorn, Inc.
11.3.3 Mylan N.V.
11.3.4 Mallinckrodt
11.3.5 Sandoz International GmbH
11.3.6 Pfizer, Inc.
11.3.7 Sun Pharmaceutical Industries Ltd.
11.3.8 Valeant Pharmaceuticals
11.3.9 Apotex Corp.
11.3.10 Endo International plc.

Figure 1: Global: Specialty Generics Market: Sales Value (in Billion US$), 2016-2021
Figure 2: Global: Specialty Generics Market: Breakup by Route of Administration (in %), 2021
Figure 3: Global: Specialty Generics Market: Breakup by Indication (in %), 2021
Figure 4: Global: Specialty Generics Market: Breakup by Distribution Channel (in %), 2021
Figure 5: Global: Specialty Generics Market: Breakup by Region (in %), 2021
Figure 6: Global: Specialty Generics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 7: Global: Specialty Generics Industry: SWOT Analysis
Figure 8: Global: Specialty Generics Industry: Value Chain Analysis
Figure 9: Global: Specialty Generics Industry: Porter’s Five Forces Analysis
Figure 10: Global: Specialty Generics Market (Administration through Injectables): Sales Value (in Billion US$), 2016 & 2021
Figure 11: Global: Specialty Generics Market (Administration through Injectables) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 12: Global: Specialty Generics Market (Oral Administration): Sales Value (in Billion US$), 2016 & 2021
Figure 13: Global: Specialty Generics Market (Oral Administration) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 14: Global: Specialty Generics Market (Other Routes of Administration): Sales Value (in Billion US$), 2016 & 2021
Figure 15: Global: Specialty Generics Market (Other Routes of Administration) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 16: Global: Specialty Generics Market (Oncology): Sales Value (in Billion US$), 2016 & 2021
Figure 17: Global: Specialty Generics Market (Oncology) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 18: Global: Specialty Generics Market (Autoimmune Diseases): Sales Value (in Billion US$), 2016 & 2021
Figure 19: Global: Specialty Generics Market (Autoimmune Diseases) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 20: Global: Specialty Generics Market (Infectious Diseases): Sales Value (in Billion US$), 2016 & 2021
Figure 21: Global: Specialty Generics Market (Infectious Diseases) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 22: Global: Specialty Generics Market (Other Indications): Sales Value (in Billion US$), 2016 & 2021
Figure 23: Global: Specialty Generics Market (Other Indications) Forecast: Sales Value (in Billion US$), 2022-2027
Figure 24: Global: Specialty Generics Market: Sales Through Retail Pharmacies (in Billion US$), 2016 & 2021
Figure 25: Global: Specialty Generics Market Forecast: Sales Through Retail Pharmacies (in Billion US$), 2022-2027
Figure 26: Global: Specialty Generics Market: Sales Through Specialty Pharmacies (in Billion US$), 2016 & 2021
Figure 27: Global: Specialty Generics Market Forecast: Sales Through Specialty Pharmacies (in Billion US$), 2022-2027
Figure 28: Global: Specialty Generics Market: Sales Through Hospital Pharmacies (in Billion US$), 2016 & 2021
Figure 29: Global: Specialty Generics Market Forecast: Sales Through Hospital Pharmacies (in Billion US$), 2022-2027
Figure 30: North America: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 32: North America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: United States: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: United States: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Canada: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Canada: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Europe: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Europe: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 39: Europe: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Italy: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Italy: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Germany: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Germany: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: France: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: France: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: United Kingdom: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: United Kingdom: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Spain: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Spain: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Asia Pacific: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Asia Pacific: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 52: Asia Pacific: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: China: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: China: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: India: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: India: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: South Korea: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: South Korea: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Latin America: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Latin America: Specialty Generics Market: Breakup by Country (in %), 2021
Figure 63: Latin America: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Brazil: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Brazil: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Mexico: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Mexico: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Middle East and Africa: Specialty Generics Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Middle East and Africa: Specialty Generics Market Forecast: Sales Value (in Million US$), 2022-2027

★調査レポート[世界の特殊ジェネリック医薬品市場予測2022年-2027年] (コード:IMARC22JN916)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の特殊ジェネリック医薬品市場予測2022年-2027年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆